NCT01833078View on ClinicalTrials.gov

Ghrelin Repeated Dose Study

PHASE2CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Frailty in Aging
Interventions
DRUG

ghrelin

ghrelin administration subcutaneously for 7 days

Trial Locations (1)

19104

University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

University of Pennsylvania

OTHER

NCT01833078 - Ghrelin Repeated Dose Study | Biotech Hunter | Biotech Hunter